Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma

J Neurooncol. 2024 Jun;168(2):375-376. doi: 10.1007/s11060-024-04666-7. Epub 2024 Apr 15.

Authors

Liam Wilson¹, Aline Atallah², Joan Miguel Romero²

Affiliations

¹ Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada. [email protected].
² Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.

PMID: 38619776
DOI: 10.1007/s11060-024-04666-7

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antineoplastic Agents, Alkylating / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bevacizumab* / therapeutic use
Brain Neoplasms* / drug therapy
Female
Glioblastoma* / drug therapy
Humans
Male
Middle Aged
Neoadjuvant Therapy* / methods
Temozolomide* / therapeutic use

Substances

Temozolomide
Bevacizumab
Antineoplastic Agents, Alkylating